SELLAS Life Sciences Group Inc.

SLS | NASDAQ

Price Alert Chart Builder DCF Calculator

$11.38

-$0.11 (-0.96%)

At close: Sep 21, 2026, 4:00 PM ET

$11.34

-$0.04 (-0.35%)

Pre-market: Sep 22, 2026, 9:21 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $2.12B

Enterprise Value $1.98B

Beta 2.53

Average Volume 8.68M

Shares Outstanding (Diluted) 189.18M

Shares Change YoY 91.95%

Institutional Ownership 31.29%

Exchange NASDAQ

ISIN US81642T2096

Price Performance

Price Change 1M -26.3%

Price Change 3M 25.5%

Price Change 6M 114.7%

Price Change YTD 161.6%

Price Change 1Y 561.6%

Price Change 3Y 653.6%

Price Change 5Y 13.6%

1M CAGR (ann.) -5.3%

1Y CAGR (ann.) 606.2%

5Y CAGR (ann.) 3.3%

All-Time CAGR -42.4%

Valuation

PE Ratio -54.19

Forward PE N/A

PEG Ratio -1.17

Forward PEG 1.00

PS Ratio N/A

Forward PS 39.90

PB Ratio 15.38

P/FCF Ratio -74.46

P/Adj. FCF Ratio -67.87

P/OCF Ratio -75.87

EV/Sales N/A

EV/EBIT -60.96

EV/EBITDA -77.97

EV/FCF -69.62

Earnings Yield -1.9%

FCF Yield -1.3%

Adj. FCF Yield -1.5%

Financial Health

Net Cash $137.71M

Total Debt $737K

Cash & Short-Term Investments $138.44M

Total Assets $145.38M

Current Ratio 18.83

Quick Ratio 18.83

Debt / Equity Ratio 0.01

Debt / EBITDA -0.03

Debt / FCF -0.03

OCF / Debt -38.57

Interest Coverage 0.00

Altman Z-Score 161.82

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -9.7%

Returns

Return on Assets -22.3%

Return on Equity -35.9%

Return on Invested Capital -25.4%

Return on Capital Employed -25.6%

Return on Tangible Assets -22.6%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y -100.0%

Revenue CAGR 10Y -4.9%

EPS CAGR 3Y 73.5%

EPS CAGR 5Y 51.0%

EPS CAGR 10Y 49.6%

FCF CAGR 3Y 18.3%

FCF CAGR 5Y -1.8%

FCF CAGR 10Y -4.9%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 5

EPS Growth Next 3Y 228.6%

Revenue Growth Next 3Y N/A

Earnings Date Nov 10, 2026

EPS Estimate (next Q) -$0.05

EPS Growth Est (next Q) -16.7%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $35

Price Target Upside 207.6%

Cash Flow

Operating Cash Flow $-28.42M

Free Cash Flow $-28.42M

Adj. Free Cash Flow $-31.19M

FCF Per Share -$0.15

OCF Per Share -$0.15

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-35.22M

EBITDA $-25.38M

Net Income $-32.46M

EPS (Diluted) -$0.21

Revenue / Employee N/A

Profit / Employee $-2.5M

Employees 13